
Jake Becraft is the CEO and Co-founder of Strand Therapeutics, a company building one of the most advanced programmable genetic medicine platforms in biotechnology. Under his leadership, Strand is redefining what RNA medicines can do by enabling cell-selective targeting and therapeutic payload delivery inside the body, unlocking a new class of precision genetic therapies. He has guided the company from its founding vision through platform development and into clinical translation, positioning Strand at the forefront of next generation RNA therapeutics.
Beyond his role at Strand, Dr. Becraft is an influential voice in the national biotechnology landscape. He engages and advises policymakers, defense leaders, and industry stakeholders on biosecurity, innovation strategy, and strengthening American competitiveness in advanced biotechnology. Trained as a synthetic biologist at MIT, he operates at the intersection of science, entrepreneurship, and policy, focused on building both the companies and the institutional frameworks required to secure the future of programmable medicine.
He received his Ph.D. in Biological Engineering and Synthetic Biology from MIT. He serves on the board of the Biotechnology Innovation Organization (BIO) and the Massachusetts Biotechnology Council (MassBio).
Please enjoy!
This episode is brought to you by:
- Helix Sleep premium mattresses: HelixSleep.com/Tim (20% off any purchase)
- Incogni, which automatically removes your personal data from the web, helping shield you from fraud, scams, and identity theft: Incogni.com/Tim (use code TIM at checkout and get 60% off an annual plan)
Additional podcast platforms
Listen to this episode on Apple Podcasts, Spotify, Overcast, Podcast Addict, Pocket Casts, Castbox, YouTube Music, Amazon Music, Audible, or on your favorite podcast platform.
Transcripts
- This episode (coming soon)
- All episodes
SELECTED LINKS FROM THE EPISODE
- Connect with Jacob Becraft:
Books, Movies, & Recommended Reading
- Genentech: The Beginnings of Biotech by Sally Smith Hughes | Amazon
- All of Jeff Bezos’ Amazon Letters to Shareholders, 1997–2020 | Quartr
- STX-001 ASCO Poster | Journal of Clinical Oncology
- Sophie’s Choice | Prime Video
- The Orphan Drug Act (ODA) | Wikipedia
- Apple, Its Control Over the iPhone, and The Internet | Matthew Ball
- How Smartphones Changed Music and the Music Industry | Hypebot
- The US Can’t Afford to Offshore Clinical Trials to China | The Washington Post
- This May Be the Most Important Medical Story of the Decade | The New York Times
Companies
- Strand Therapeutics
- Amazon
- Andreessen Horowitz
- Anthropic
- Apple
- AWS (Amazon Web Services)
- BlackBerry
- Bristol Myers Squibb (BMS)
- DeepMind
- Domino’s (Domino’s Pizza)
- Genentech
- Genzyme
- Holobiome
- Merck
- Meta
- Microsoft
- Moderna
- Netflix
- The New York Times
- OpenAI
- PayPal
- PickFu
- Playground Global
- Polymarket
- SpaceX
- Spotify
- Sweetgreen
- Tesla
- Thrive Capital
- Uber
- Uber Eats
- The Washington Post
- Zenno
- Zip2
Institutions & Organizations
- American Society of Clinical Oncology (ASCO)
- Center for Biologics Evaluation and Research (CBER)
- Congress (US)
- Clinical Trial Notification (CTN) (Australia)
- Department of Health (Abu Dhabi)
- European Medicines Agency (EMA)
- Food and Drug Administration (FDA)
- Institutional Review Board (IRB)
- Medicaid
- Medicare
- MIT
- MIT Media Lab
- MD Anderson Cancer Center
- Memorial Sloan Kettering Cancer Center
- Nobel Prize
- The White House
Concepts
- Abscopal Effect in Oncology
- American Society of Clinical Oncology (ASCO) Annual Meeting
- Australia’s Clinical Trial Notification (CTN) Scheme
- CAR-T Cell Therapy: Cost and Manufacturing Challenges
- The Central Dogma of Molecular Biology (DNA → RNA → Protein)
- Checkpoint Inhibitors and Cancer Immunotherapy
- Cutaneous vs. Visceral Metastases in Melanoma
- FDA Investigational New Drug (IND) Application
- First Principles Thinking (Elon Musk / SpaceX)
- In Vivo CAR-T Cell Therapy
- Institutional Review Boards (IRBs) and Clinical Trial Oversight
- Kaplan-Meier Survival Curves
- Keytruda (Pembrolizumab) by Merck
- mRNA-Based Therapeutics
- Strand’s STX-001: Phase 1 Trial in Solid Tumors
People
- Jeff Bezos
- Jennifer Doudna
- Jony Ive
- Steve Jobs
- Steve Jurvetson
- Baby KJ
- Josh Kushner
- Art Levinson
- Martin Makary
- Jamie Metzl
- Elon Musk
- Sundar Pichai
- Vinay Prasad
- Phil Strandwitz
- Henri Termeer
This episode is brought to you by Incogni: erase your personal data from the web and prevent scams, fraud, and identity theft! Incogni automatically removes your information across 420+ data brokers (1,000+ additional sites covered in their Unlimited plan), and they keep it scrubbed automatically. Deloitte has independently verified the headline numbers (245M+ removal requests), and the company adheres to AICPA SOC security standards, with an A+ rating from the BBB. And with their Unlimited plan, if you find your info on a site they don’t automatically monitor, just send them the link, and their privacy team will handle it. Protect yourself now with Incogni. Go to Incogni.com/Tim to get 60% off their annual plan.
This episode is brought to you by Helix Sleep! Helix was selected as the best overall mattress of 2025 by Forbes and Wired magazines and best in category by Good Housekeeping, GQ, and many others. With Helix, there’s a specific mattress to meet each and every body’s unique comfort needs. Just take their quiz—only two minutes to complete—that matches your body type and sleep preferences to the perfect mattress for you. They have a 10-year warranty, and you get to try it out for a hundred nights, risk-free. They’ll even pick it up from you if you don’t love it. And now, Helix is offering listeners 20% off all mattress orders for a limited time at HelixSleep.com/Tim.



Comment Rules: Remember what Fonzie was like? Cool. That's how we're gonna be — cool. Critical is fine, but if you're rude, we'll delete your stuff. Please do not put your URL in the comment text and please use your PERSONAL name or initials and not your business name, as the latter comes off like spam. Have fun and thanks for adding to the conversation! (Thanks to Brian Oberkirch for the inspiration.)